Pacritinib - CAS# 937272-79-2 adib) 877 ng/mL for breast cancer
USD108.00
USD153.00
Pay in 4 interest-free payments of $27.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Live Spec
Pacritinib - CAS# 937272-79-2 adib) 877 ng/mL for breast cancerPacritinib, also known as SB1518, is a n orally bioavailable inhibitor of Janus kinase 2 (JAK2) and the JAK2 mutant JAK2V617F with potential antineoplastic activity. Pacritinib competes with JAK2 for ATP binding, which may result in inhibition of JAK2 activation, inhibition of the JAK STAT signaling pathway, and so caspase dependent apoptosis. JAK2 is the most common mutated gene in bcr abl negative myeloproliferative disorders; the JAK2V617F gain of
Store: www.drbramiyohan.com · Domain: www.drbramiyohan.com
